Warsaw Genomics
PL Order test

Cancers

About this category
Our panels enable precise diagnostics of mutations that determine the development of cancers. The clinical rationale for the analysis of genes included in cancer panels has been confirmed in many databases, guidelines of medical societies and literature data.

The analysis of disorders in genes associated with the development of cancers can be assessed by identifying germinal (hereditary) and somatic (non-inherited) mutations.

Identification of the germinal mutation allows to determine the probability of developing the disease in a healthy patient with a family history of cancers, allowing for taking preventive measures. Identification of a germinal mutation in a patient suffering from cancer may allow for the determination of appropriate therapy and provides information about the possibility of passing the mutation on to children. Indication of somatic mutations also allows the implementation of an appropriate treatment plan for the patient.

All genetic tests are performed using the next-generation sequencing method, using Illumina sequencers. Our tests are subject to internal and external control. The laboratory is subject to continuous external quality control.

Panels in this category

47 panels

Not sure which test to choose?

Book a consultation with a clinical geneticist, or get in touch — we'll help you choose the right test.

Get a clinical consultation Contact us